Safety of Nasal Influenza Immunisation in Children With Asthma

PHASE4CompletedINTERVENTIONAL

Enrollment

479

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Asthma

Interventions

DRUG

Administration of Live attenuated influenza vaccine (LAIV)

All Listed Sponsors

collaborator

Public Health England

OTHER_GOV

lead

Imperial College London

OTHER

NCT02866942 - Safety of Nasal Influenza Immunisation in Children With Asthma | Biotech Hunter | Biotech Hunter